Original Articles

Diagnostic Accuracy of Transcutaneous Bilirubinometry Versus Serum Bilirubin Level

  1. Postgraduate Resident, The children Hospital, PIMS, Islamabad
  2. Professor of Neonatology, The children Hospital, PIMS, Islamabad
  3. Medical officer RIC,
  4. Postgraduate resident, The children Hospital, PIMS, Islamabad
https://doi.org/10.48036/apims.v21i1.762

Abstract

Objective: To assess the diagnostic accuracy of transcutaneous bilirubinometry over serum bilirubin level in newborns with hyperbilirubinemia.

Methodology: This cross-sectional study was conducted at Department of Neonatology, Children Hospital, PIMS Islamabad for six months from 01-09-20 to 28-02-21, included 150 jaundiced neonates of any gender over six months. Exclusion criteria included pre-treated hyperbilirubinemia, very premature or low birth weight infants, congenital abnormalities, or infants of jaundiced mothers. Post ethical clearance and parental consent, neonates were evaluated using the MBJ-20 transcutaneous bilirubinometer, with results compared to serum bilirubin levels. The study identified true and false diagnostic outcomes based on a ?12 mg/dL bilirubin threshold, signifying phototherapy initiation. Data analysis was performed with SPSS 26.0, calculating sensitivity, specificity, and accuracy, and determining diagnostic congruence through Pearson’s correlation and ROC AUC, with a significance threshold at p<0.05.

Results: The mean serum bilirubin level and transcutaneous bilirubin levels were 14.28 ± 2.21 mg/dL and 14.52 ± 2.72 mg/dL respectively, with a mean difference of 0.24± 1.38 mg/dL (t(149) = 2.141, p = .034). This difference demonstrating a statistically significant overestimation compared to serum bilirubin levels. The correlation between transcutaneous and serum bilirubin levels was strong (r = 0.864, p < 0.0001). For the 12 mg/dL phototherapy threshold, the transcutaneous method showed high sensitivity (95.59%) and specificity (78.57%), with an overall test accuracy of 94%. The Area Under the Curve (AUC) for the receiver operating characteristic was 0.962, indicating high diagnostic precision.

Conclusion: Transcutaneous bilirubinometry is a low-cost, noninvasive, and accurate screening test for hyperbilirubinemia with a high sensitivity specificity and positive predictive value (PPV).

Metrics

1,027Abstract views
584Downloads

Full Text

License

Copyright (c) 2024 KINZA IMRAN

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0/.) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More in this Issue